Goeltz II Robert C. sold RCUS
October 28, 2025 · Form 4 insider transaction
Goeltz II Robert C. sold 5,000 shares of Arcus Biosciences, Inc. at $20.00 per share, a transaction worth $100.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,000
Price
$20.00
Total value
$100.0K
InsiderGoeltz II Robert C.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 28, 2025
Filing dateOctober 29, 2025
Shares owned after92,138
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.